132 related articles for article (PubMed ID: 12798087)
1. Engaging the community in research: lessons learned from the malaria vaccine trial.
Reeder JC; Taime J
Trends Parasitol; 2003 Jun; 19(6):281-2. PubMed ID: 12798087
[TBL] [Abstract][Full Text] [Related]
2. The malaria vaccine development program in Papua New Guinea.
Genton B; Anders RF; Alpers MP; Reeder JC
Trends Parasitol; 2003 Jun; 19(6):264-70. PubMed ID: 12798084
[TBL] [Abstract][Full Text] [Related]
3. Health research in Papua New Guinea.
Reeder JC
Trends Parasitol; 2003 Jun; 19(6):241-5. PubMed ID: 12798079
[TBL] [Abstract][Full Text] [Related]
4. The Malaria Vaccine Epidemiology and Evaluation Project of Papua New Guinea: rationale and baseline studies.
Alpers MP; al-Yaman F; Beck HP; Bhatia KK; Hii J; Lewis DJ; Paru R; Smith TA
P N G Med J; 1992 Dec; 35(4):285-97. PubMed ID: 1341090
[TBL] [Abstract][Full Text] [Related]
5. Towards a malaria vaccine for Papua New Guinea.
Reeder JC
P N G Med J; 2001; 44(1-2):17-23. PubMed ID: 12418674
[TBL] [Abstract][Full Text] [Related]
6. Vaccines against malaria: perspectives from Papua New Guinea.
Mueller I; Genton B; Betuela I; Alpers MP
Hum Vaccin; 2010 Jan; 6(1):17-20. PubMed ID: 20173407
[TBL] [Abstract][Full Text] [Related]
7. Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: development of study site infrastructure and lessons learned.
Odero NA; Samuels AM; Odongo W; Abong'o B; Gimnig J; Otieno K; Odero C; Obor D; Ombok M; Were V; Sang T; Hamel MJ; Kachur SP; Slutsker L; Lindblade KA; Kariuki S; Desai M
Malar J; 2019 Jul; 18(1):255. PubMed ID: 31357997
[TBL] [Abstract][Full Text] [Related]
8. Update on the clinical development of candidate malaria vaccines.
Ballou WR; Arevalo-Herrera M; Carucci D; Richie TL; Corradin G; Diggs C; Druilhe P; Giersing BK; Saul A; Heppner DG; Kester KE; Lanar DE; Lyon J; Hill AV; Pan W; Cohen JD
Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):239-47. PubMed ID: 15331843
[TBL] [Abstract][Full Text] [Related]
9. Interpreting challenge data from early phase malaria blood stage vaccine trials.
Good MF; Miller LH
Expert Rev Vaccines; 2018 Mar; 17(3):189-196. PubMed ID: 29382292
[TBL] [Abstract][Full Text] [Related]
10. Malaria vaccine trials.
Greenwood B; Alonso P
Chem Immunol; 2002; 80():366-95. PubMed ID: 12058650
[No Abstract] [Full Text] [Related]
11. Implications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines.
Fowkes FJ; Simpson JA; Beeson JG
BMC Med; 2013 Oct; 11():232. PubMed ID: 24228861
[TBL] [Abstract][Full Text] [Related]
12. 'He is now like a brother, I can even give him some blood'--relational ethics and material exchanges in a malaria vaccine 'trial community' in The Gambia.
Geissler PW; Kelly A; Imoukhuede B; Pool R
Soc Sci Med; 2008 Sep; 67(5):696-707. PubMed ID: 18455854
[TBL] [Abstract][Full Text] [Related]
13. Malaria vaccines. Evaluation and implementation.
Greenwood B
Acta Trop; 2005 Sep; 95(3):298-304. PubMed ID: 15955523
[TBL] [Abstract][Full Text] [Related]
14. Sustainable development of a GCP-compliant clinical trials platform in Africa: the malaria clinical trials alliance perspective.
Ogutu BR; Baiden R; Diallo D; Smith PG; Binka FN
Malar J; 2010 Apr; 9():103. PubMed ID: 20406478
[TBL] [Abstract][Full Text] [Related]
15. Clinical development of malaria vaccines: should earlier trials be done in malaria endemic countries?
Chilengi R
Hum Vaccin; 2009 Sep; 5(9):627-36. PubMed ID: 19617708
[TBL] [Abstract][Full Text] [Related]
16. Malaria vaccine trial endpoints - bridging the gaps between trial design, public health and the next generation of vaccines.
O'Meara WP; Lang T
Parasite Immunol; 2009 Sep; 31(9):574-81. PubMed ID: 19691560
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity.
Genton B; al-Yaman F; Beck HP; Hii J; Mellor S; Narara A; Gibson N; Smith T; Alpers MP
Ann Trop Med Parasitol; 1995 Aug; 89(4):359-76. PubMed ID: 7487223
[TBL] [Abstract][Full Text] [Related]
18. Understanding protective immune mechanisms induced by malaria vaccines in the context of clinical trials.
Dobaño C; Campo JJ
Hum Vaccin; 2009 Aug; 5(8):562-5. PubMed ID: 19287202
[TBL] [Abstract][Full Text] [Related]
19. Mapping the prevalence of malaria in rural Papua New Guinea using a geographic information system.
Namosha E; Mueller I; Kastens W; Kiele R; Kasehagen L; Siba PM
P N G Med J; 2010; 53(1-2):5-14. PubMed ID: 22768474
[TBL] [Abstract][Full Text] [Related]
20. Progress and challenges for malaria vaccines.
Richie TL; Saul A
Nature; 2002 Feb; 415(6872):694-701. PubMed ID: 11832958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
